Abstract
This paper describes a variety of issues in the design and analysis of multiclinic trials, focusing in particular on the detection and interpretation of treatment-by-clinic interaction. First Fleiss, which represents the classical approach and covers such issues as pooling the data, fixed versus random effects, and the analysis of main effects in the presence of interaction, is reviewed. Next, different methods for distinguishing quantitative from qualitative interaction are reviewed, and the influence of scale transformations on the interpretation of interaction is discussed. Finally, nonparametric procedures for detecting treatment-by-center interaction are reviewed and the advantages of the Iman/Conover-type ranking procedure are described.
Get full access to this article
View all access options for this article.
